Doctor profile · Federal record
Dr. Rami Eltaraboulsi, M.D.
Rheumatology Physician (CMS: Rheumatology) · Rockville, MD
- NPI 1427477363
- Accepts Medicare
- MIPS 77.1 / 100 · 2023
- 6 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
14995 Shady Grove RD Ste 250
Rockville, MD 208508727
(301) 942-7600
fax (301) 217-9241 - Mailing address
-
7361 Calhoun Pl Ste 600
Rockville, MD 208552788
Credentials & registration
- NPI registered
- April 2014 — 12 yrs on file
- Profile last updated
- February 17, 2026
- Year of graduation
- 2020 — 6 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Maryland #D0089215
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427477363. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
80,163
Distinct HCPCS
10
Medicare allowed
$1,357,179
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 24,230 | 12 | $6 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 21,420 | 32 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 11,940 | 176 | $23 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 5,500 | 15 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,240 | 24 | $33 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,025 | 13 | $42 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 1,940 | 14 | $34 | |
J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 1,875 | 16 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 883 | 409 | $145 | |
80053 |
Blood test, comprehensive group of blood chemicals | 597 | 363 | $10 |
In context: peer comparison
Among 8 peers in Rockville Rheumatology Physician, average services per provider: 1,219. This provider delivers 66× the peer median.Open Payments
Industry payments received
All-time total
$90
Transactions
4
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 4 | $90.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
861
Patients
258
Total drug cost
$482,603
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Alendronate Sodium | Generic | 171 | 63 | $2,750 |
| Allopurinol | Generic | 109 | 29 | $1,755 |
| Meloxicam | Generic | 87 | 34 | $790 |
| Prednisone | Generic | 81 | 30 | $786 |
| Methotrexate (Methotrexate Sodium) | Brand | 71 | 20 | $2,994 |
| Hydroxychloroquine Sulfate | Generic | 58 | 19 | $4,403 |
| Colchicine | Generic | 50 | 21 | $8,670 |
| Gabapentin | Generic | 49 | 18 | $826 |
| Humira(Cf) Pen (Adalimumab) | Brand | 36 | 0 | $335,105 |
| Duloxetine Hcl | Generic | 35 | 12 | $1,063 |
Frequently asked questions
What is Dr. Rami Eltaraboulsi's medical specialty?
Dr. Rami Eltaraboulsi practices Rheumatology Physician in Rockville, MD.
Where does Dr. Rami Eltaraboulsi practice?
Dr. Rami Eltaraboulsi practices at 14995 Shady Grove RD Ste 250, Rockville, MD 208508727. Office phone: 3019427600.
What is Dr. Rami Eltaraboulsi's NPI?
Dr. Rami Eltaraboulsi's National Provider Identifier (NPI) is 1427477363, issued by NPPES.
Does Dr. Rami Eltaraboulsi accept Medicare assignment?
Yes. Dr. Rami Eltaraboulsi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rami Eltaraboulsi commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.